financetom
Business
financetom
/
Business
/
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
Nov 11, 2024 5:52 AM

08:28 AM EST, 11/11/2024 (MT Newswires) -- Full Circle Lithium ( FCLIF ) , a U.S.-based lithium-products manufacturer, on Monday said that sales of FCL-X, the company's lithium-ion battery fire-extinguishing agent, has surpassed US$300,000.

"We are very pleased to see that we achieved meaningful non-recurring sales of FCL-X in all product lines in the past few weeks even though we have just begun our marketing and sales efforts, including signing up with US specialty fire safety distributor AEST Fire & Safety," said CEO Carlos Vicens.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OpenAI will reserve portion of IPO shares for retail investors, CFO tells CNBC
OpenAI will reserve portion of IPO shares for retail investors, CFO tells CNBC
Apr 8, 2026
April 8 (Reuters) - OpenAI plans to reserve a portion of its shares from an initial public offering for individual investors, CFO Sarah Friar told CNBC on Wednesday, as the ChatGPT maker gears up for a highly anticipated U.S. stock market listing. The AI startup is laying the groundwork for an IPO that could value it at up to $1 trillion...
Vanda Pharmaceuticals Starts Study of Nereus to Address GLP-1 Side Effects
Vanda Pharmaceuticals Starts Study of Nereus to Address GLP-1 Side Effects
Apr 8, 2026
05:33 PM EDT, 04/08/2026 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) initiated a clinical trial evaluating Nereus for the prevention of vomiting in patients receiving GLP-1 receptor agonist therapies. The randomized, double-blind, placebo-controlled trial will assess the safety and efficacy of oral Nereus in patients starting high-dose GLP-1 therapy, with the primary endpoint being the percentage of patients who...
Dover's Advansor Unveils High-Capacity Carbon Dioxide System
Dover's Advansor Unveils High-Capacity Carbon Dioxide System
Apr 8, 2026
05:39 PM EDT, 04/08/2026 (MT Newswires) -- Dover (DOV) said Wednesday its unit Advansor has launched the SteelXL Heat Pump, a high-capacity carbon dioxide system for food processing, district heating, and large commercial buildings. The system has a total capacity of up to 50 megawatts, making it well-suited for a variety of industrial heating, ventilation, and air conditioning applications, it...
OpenAI will reserve portion of IPO shares for retail investors, CFO tells CNBC
OpenAI will reserve portion of IPO shares for retail investors, CFO tells CNBC
Apr 8, 2026
April 8 (Reuters) - OpenAI plans to reserve a portion of its shares from an initial public offering for individual investors, CFO Sarah Friar told CNBC on Wednesday, as the ChatGPT maker gears up for a highly anticipated U.S. stock market listing. The AI startup is laying the groundwork for an IPO that could value it at up to $1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved